Recent Advances in Adjuvant Endocrine Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer

被引：0
|
作者：
Cobain, Erin F. [1 ]
Hayes, Daniel F. [1 ]
机构：
[1] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 32期
关键词：
PATIENT-LEVEL METAANALYSIS; RIBOCICLIB PLUS FULVESTRANT; CELL-FREE DNA; POSTMENOPAUSAL WOMEN; MUTATIONS; LETROZOLE; SURVIVAL; TRIAL; MULTICENTER; PALBOCICLIB;
D O I：
10.1200/JCO.22.00702
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：3673 / +
页数：5
相关论文
共 50 条
  • [1] Everolimus Plus Endocrine Therapy for Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer A Clinical Trial
    Royce, Melanie
    Bachelot, Thomas
    Villanueva, Cristian
    Ozguroglu, Mustafa
    Azevedo, Sergio J.
    Cruz, Felipe Melo
    Debled, Marc
    Hegg, Roberto
    Toyama, Tatsuya
    Falkson, Carla
    Jeong, Joon
    Srimuninnimit, Vichien
    Gradishar, William J.
    Arce, Christina
    Ridolfi, Antonia
    Lin, Chinjune
    Cardoso, Fatima
    JAMA ONCOLOGY, 2018, 4 (07) : 977 - 984
  • [2] Advances in endocrine and targeted therapy for hormone-receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
    Shen, Le-Sang
    Jin, Xiao-Yan
    Wang, Xu-Meng
    Tou, Lai-Zhen
    Huang, Jian
    CHINESE MEDICAL JOURNAL, 2020, 133 (09) : 1099 - 1108
  • [3] Ribociclib for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
    Burris, Howard A., III
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (03) : 201 - 213
  • [4] Safety and Antitumor Activity of Pembrolizumab in Patients with Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer
    Rugo, Hope S.
    Delord, Jean-Pierre
    Im, Seock-Ah
    Ott, Patrick A.
    Piha-Paul, Sarina A.
    Bedard, Philippe L.
    Sachdev, Jasgit
    Le Tourneau, Christophe
    van Brummelen, Emilie M. J.
    Varga, Andrea
    Salgado, Roberto
    Loi, Sherene
    Saraf, Sanatan
    Pietrangelo, Dina
    Karantza, Vassiliki
    Tan, Antoinette R.
    CLINICAL CANCER RESEARCH, 2018, 24 (12) : 2804 - 2811
  • [5] Everolimus Added to Adjuvant Endocrine Therapy in Patients With High-Risk Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer
    Bachelot, Thomas
    Cottu, Paul
    Chabaud, Sylvie
    Dalenc, Florence
    Allouache, Djelila
    Delaloge, Suzette
    Jacquin, Jean-Philippe
    Grenier, Julien
    Bouvet, Laurence Venat
    Jegannathen, Apurna
    Campone, Mario
    Del Piano, Francesco
    Debled, Marc
    Hardy-Bessard, Anne-Claire
    Giacchetti, Sylvie
    Mouret-Reynier, Marie-Ange
    Barthelemy, Philippe
    Kaluzinski, Laure
    Mailliez, Audrey
    Legouffe, Eric
    Sephton, Matthew
    Bliss, Judith
    Canon, Jean-Luc
    Penault-Llorca, Frederique
    Lemonnier, Jerome
    Cameron, David
    Andre, Fabrice
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (32) : 3699 - +
  • [6] Individualizing Adjuvant Therapy in Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Node-Positive Breast Cancer
    Gogineni, Keerthi
    Kalinsky, Kevin
    JCO ONCOLOGY PRACTICE, 2022, 18 (04) : 247 - +
  • [7] Endocrine Treatment and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: ASCO Guideline Update
    Burstein, Harold J.
    Somerfield, Mark R.
    Barton, Debra L.
    Dorris, Ali
    Fallowfield, Lesley J.
    Jain, Dharamvir
    Johnston, Stephen R. D.
    Korde, Larissa A.
    Litton, Jennifer K.
    Macrae, Erin R.
    Peterson, Lindsay L.
    Vikas, Praveen
    Yung, Rachel L.
    Rugo, Hope S.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (35) : 3959 - +
  • [8] Combination of Palbociclib and Endocrine Therapy in Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer With or Without Brain Metastases
    Zhang, Qiuyi
    Lan, Xiaofeng
    Huang, Jiayi
    Xie, Xiaofeng
    Chen, Liping
    Song, Lin
    Bai, Xue
    Chen, Xuelian
    Jing, Haiman
    Du, Caiwen
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2024, 23
  • [9] Systemic therapy for hormone receptor-positive/human epidermal growth factor receptor 2-negative early stage and metastatic breast cancer
    Huppert, Laura A.
    Gumusay, Ozge
    Idossa, Dame
    Rugo, Hope S.
    CA-A CANCER JOURNAL FOR CLINICIANS, 2023, 73 (05) : 480 - 515
  • [10] Fulvestrant in the treatment of hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: A review
    Li, Junjie
    Wang, Zhonghua
    Shao, Zhimin
    CANCER MEDICINE, 2019, 8 (05): : 1943 - 1957
12345